53BP1 ablation rescues genomic instability in mice expressing 'RING-less' BRCA1.

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• BRCA1 mutations are linked to breast and ovarian cancers.
• The precise tumor-suppressive mechanism of BRCA1 remains incompletely understood.
• BRCA1's N-terminal RING domain is crucial for its function.

Purpose of the Study:

• To investigate the functional consequences of a BRCA1 isoform lacking the N-terminal RING domain.
• To elucidate the role of BRCA1 in maintaining genomic stability.
• To explore the interplay between BRCA1, RAD51, 53BP1, and BARD1 in DNA damage response.

Main Methods:

• Generated mice with homozygous deletion of exon 2 in the Brca1 gene, resulting in a "RING-less" BRCA1 isoform.
• Assessed protein stability, recruitment to DNA damage sites, and RAD51 foci formation in cells expressing RING-less BRCA1.
• Analyzed genomic instability, tumor susceptibility, and BARD1 levels in mice and cells.
• Investigated the effect of Trp53bp1 deletion on genomic instability in the context of RING-less BRCA1.

Main Results:

• Mice expressing RING-less BRCA1 exhibit significant genomic instability despite efficient RAD51 foci formation.
• Genomic instability is rescued by the deletion of Trp53bp1 (encoding 53BP1).
• Mice expressing RING-less BRCA1 do not show increased tumor susceptibility when 53BP1 is absent.
• Instability correlates with BARD1 loss and impaired replication fork restart, suggesting a RAD51-independent role for BRCA1-BARD1.

Conclusions:

• The N-terminal RING domain of BRCA1 is essential for preventing genomic instability, independent of its role in RAD51 loading.
• BRCA1-BARD1 complex plays a critical role in maintaining genomic integrity, particularly in replication fork restart.
• Targeting 53BP1 could be a therapeutic strategy for BRCA1-related cancers exhibiting genomic instability.